Germany rejects U.S. proposal to waive patents on COVID-19 vaccines
BERLIN (Reuters) -Germany on Thursday rejected a U.S. proposal to waive patent protection for COVID-19 vaccines, saying the greatest constraints on production were not intellectual property but increasing capacity and ensuring quality.
President Joe Biden on Wednesday voiced support for a waiver in a sharp reversal of the U.S. position, and his top trade negotiator, Katherine Tai, swiftly backed negotiations at the World Trade Organization.
The German government stood behind the goal of a worldwide supply of COVID-19 vaccines, a government spokeswoman said, adding however that the main factors in vaccine production are capacity and quality standards, and not patents.
"The protection of intellectual property is a source of innovation and must remain so in the future," the spokeswoman said in a statement.
https://www.yahoo.com/news/germany-opposes-u-plan-waive-154543554.html
